Osteoarthritis (OA) and rheumatoid arthritis (RA) are among the most prevalent chronic illnesses and leading causes of disability in the United States. The enzymes responsible for these two illnesses are named COX-1 and COX-2, and have been the target of arthritis therapy using nonselective NSAIDs. An understanding of the COX enzymes has allowed for the development of agents that specifically inhibit COX-2. COX-2–selective inhibitors work similar to NSAIDS, but have a lower potential for upper gastrointestinal injury, a serious side effect of nonselective NSAIDs. COX-2–selective inhibitors represent a significant advance in the treatment of arthritis and other related inflammatory conditions. Science has found that the ability to inhibit COX-2 while sparing COX-1 should provide therapeutic benefits in the management of pain and inflammation, without deleterious effects on the integrity of upper gastrointestinal tract. Vioxx is one such COX-2 inhibitor.

Wildman Schooley, LLC is committed to promoting the heightened quality and safety of medications marketed to the public by taking swift legal action to compensate injuries resulting from dangerous drugs like Vioxx. Claims for Injuries resulting from Vioxx and other prescription drugs require prompt action. If you or a loved one has suffered an injury from taking Vioxx, call Wildman Schooley, LLC now at (740) 852-8383 or Toll Free: (877) 874-8383 or CLICK HERE TO SUBMIT A SIMPLE CASE FORM. The initial consultation is free of charge, and if we agree to accept your case, we will work on a contingent fee basis, which means we get paid for our services only if there is a monetary award or recovery of funds. Don't delay! You may have a valid claim and be entitled to compensation for your injuries, but a lawsuit must be filed before the statute of limitations expires.